UNCY - Unicycive Therapeutics, Inc.
6.59
-0.240 -3.642%
Share volume: 692,030
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$6.83
-0.24
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-14-2024 | 11-13-2024 | 05-14-2025 | 11-12-2025 | |
| Assets | ||||||
| Total Assets | 52.385 M | 44.701 M | 38.574 M | 27.947 M | 50.611 M | |
| Current Assets | 51.676 M | 44.054 M | 37.741 M | 27.346 M | 50.287 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 48.930 M | 41.780 M | 32.347 M | 19.769 M | 42.695 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 23.000 K | 43.000 K | 61.000 K | 83.000 K | 75.000 K | |
| Other Assets | 686.000 K | 604.000 K | 772.000 K | 518.000 K | 249.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 52.385 M | 44.701 M | 38.574 M | 27.947 M | 50.611 M | |
| Total liabilities | 30.654 M | 13.360 M | 10.724 M | 16.676 M | 13.131 M | |
| Total current liabilities | 30.282 M | 13.086 M | 10.459 M | 16.676 M | 13.131 M | |
| Accounts Payable | 1.240 M | 1.472 M | 548.000 K | 1.397 M | 957.000 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -24.456 M | -14.846 M | 27.850 M | 11.271 M | 37.480 M | |
| Common stock | 61.048 M | 60.803 M | 107.595 M | 111.971 M | 150.638 M | |
| Retained earnings | -85.504 M | -75.649 M | -79.745 M | -100.700 M | -113.158 M |